Published in Clin Vaccine Immunol on May 30, 2007
Attenuation of V- or C-defective measles viruses: infection control by the inflammatory and interferon responses of rhesus monkeys. J Virol (2008) 1.36
Application of pharmacogenomics to vaccines. Pharmacogenomics (2009) 1.30
Measles virus-induced suppression of immune responses. Immunol Rev (2010) 1.27
Measles virus, immune control, and persistence. FEMS Microbiol Rev (2012) 1.12
Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children. PLoS Negl Trop Dis (2012) 0.99
Differential cellular immune responses to wild-type and attenuated edmonston tag measles virus strains are primarily defined by the viral phosphoprotein gene. J Med Virol (2010) 0.92
Impaired cholesterol biosynthesis in a neuronal cell line persistently infected with measles virus. J Virol (2009) 0.90
Induction of dendritic cell production of type I and type III interferons by wild-type and vaccine strains of measles virus: role of defective interfering RNAs. J Virol (2013) 0.83
Olfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection. PLoS One (2015) 0.82
Comparison of Atlantic salmon individuals with different outcomes of cardiomyopathy syndrome (CMS). BMC Genomics (2012) 0.78
Limited in vivo production of type I or type III interferon after infection of macaques with vaccine or wild-type strains of measles virus. J Interferon Cytokine Res (2014) 0.77
Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination. PLoS One (2016) 0.76
Morbillivirus Experimental Animal Models: Measles Virus Pathogenesis Insights from Canine Distemper Virus. Viruses (2016) 0.75
The Immune Response in Measles: Virus Control, Clearance and Protective Immunity. Viruses (2016) 0.75
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature (1999) 34.47
A network-based analysis of systemic inflammation in humans. Nature (2005) 12.60
Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 10.58
Onto-Tools, the toolkit of the modern biologist: Onto-Express, Onto-Compare, Onto-Design and Onto-Translate. Nucleic Acids Res (2003) 9.30
Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature (2006) 5.19
The inflammasome: first line of the immune response to cell stress. Cell (2006) 3.73
Chemokines as regulators of T cell differentiation. Nat Immunol (2001) 3.37
Disturbances in gamma globulin synthesis as experiments of nature. Pediatrics (1956) 3.18
Macrophage inflammatory protein-1. Int J Biochem Cell Biol (2004) 3.15
Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol (2002) 2.86
Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J Biol Chem (2005) 2.27
The host response to smallpox: analysis of the gene expression program in peripheral blood cells in a nonhuman primate model. Proc Natl Acad Sci U S A (2004) 1.85
Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors. Blood (2005) 1.75
A20 is a negative regulator of IFN regulatory factor 3 signaling. J Immunol (2005) 1.63
Expression profile of immune response genes in patients with Severe Acute Respiratory Syndrome. BMC Immunol (2005) 1.61
ICAM-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol (2005) 1.55
CD83 on dendritic cells: more than just a marker for maturation. Trends Immunol (2002) 1.47
Pathogenesis of measles virus infection: an hypothesis for altered immune responses. J Infect Dis (1994) 1.44
Production of atypical measles in rhesus macaques: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med (1999) 1.35
Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis (2002) 1.31
Kinetics and expression patterns of chemokine receptors in human CD4+ T lymphocytes primed by myeloid or plasmacytoid dendritic cells. Eur J Immunol (2003) 1.29
Functional genomic relationships in HIV-1 disease revealed by gene-expression profiling of primary human peripheral blood mononuclear cells. J Infect Dis (2005) 1.24
Cutting edge: CD83 regulates the development of cellular immunity. J Immunol (2002) 1.21
GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol (2005) 1.20
Cellular immune responses during complicated and uncomplicated measles virus infections of man. Clin Immunol Immunopathol (1984) 1.18
Cytokine production in vitro and the lymphoproliferative defect of natural measles virus infection. Clin Immunol Immunopathol (1991) 1.18
Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis (2002) 1.18
Patterns of gene expression in peripheral blood mononuclear cells of rhesus macaques infected with SIVmac251 and exhibiting differential rates of disease progression. AIDS Res Hum Retroviruses (2003) 1.14
Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis (2002) 1.14
Toll-like receptor (TLR)2 and TLR4 agonists regulate CCR expression in human monocytic cells. J Immunol (2004) 1.12
Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc Natl Acad Sci U S A (2006) 1.12
Measles virus-induced modulation of host-cell gene expression. J Gen Virol (2002) 1.11
Natural measles causes prolonged suppression of interleukin-12 production. J Infect Dis (2001) 1.10
Implications of the human immunodeficiency virus epidemic for control and eradication of measles. Clin Infect Dis (1999) 1.07
Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles. Clin Diagn Lab Immunol (2002) 1.04
Measles virus infection enhances IL-1 beta but reduces tumor necrosis factor-alpha expression in human monocytes. J Immunol (1992) 1.04
Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis (2001) 1.00
Not-so-sweet sixteen: the role of IL-16 in infectious and immune-mediated inflammatory diseases. J Interferon Cytokine Res (2006) 0.99
Infection of CD4+ memory T cells by HIV-1 requires expression of phosphodiesterase 4. J Immunol (2000) 0.98
Differential signaling mechanisms regulate expression of CC chemokine receptor-2 during monocyte maturation. J Inflamm (Lond) (2005) 0.96
IL-8 responsiveness defines a subset of CD8 T cells poised to kill. Blood (2004) 0.96
CXCR2 is critical for dsRNA-induced lung injury: relevance to viral lung infection. J Inflamm (Lond) (2005) 0.96
Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells. J Immunol (2004) 0.93
Immune activation during measles: beta 2-microglobulin in plasma and cerebrospinal fluid in complicated and uncomplicated disease. J Infect Dis (1992) 0.84
The inflammatory cytokines in measles: correlation between serum interferon-gamma levels and lymphocyte subpopulations. Eur J Pediatr (1992) 0.81
Measles virus infection induces interleukin-8 release in human pulmonary epithelial cells. Comp Immunol Microbiol Infect Dis (2005) 0.79
Effectiveness of antiretroviral therapy among HIV-infected children in sub-Saharan Africa. Lancet Infect Dis (2008) 4.80
A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J (2010) 2.83
Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection. J Virol (2002) 2.55
Measles. Lancet (2011) 2.37
Global measles elimination. Nat Rev Microbiol (2006) 2.21
Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet (2005) 2.11
Do children infected with HIV receiving HAART need to be revaccinated? Lancet Infect Dis (2010) 1.94
The influence of HIV-1 exposure and infection on levels of passively acquired antibodies to measles virus in Zambian infants. Clin Infect Dis (2007) 1.89
Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis (2008) 1.83
Luciferase imaging of a neurotropic viral infection in intact animals. J Virol (2003) 1.83
Population immunity to measles virus and the effect of HIV-1 infection after a mass measles vaccination campaign in Lusaka, Zambia: a cross-sectional survey. Lancet (2009) 1.71
Barriers to the care of HIV-infected children in rural Zambia: a cross-sectional analysis. BMC Infect Dis (2009) 1.58
BAK alters neuronal excitability and can switch from anti- to pro-death function during postnatal development. Dev Cell (2003) 1.56
A sensitive genotyping assay for detection of drug resistance mutations in reverse transcriptase of HIV-1 subtypes B and C in samples stored as dried blood spots or frozen RNA extracts. J Virol Methods (2006) 1.49
HIV-infected children in rural Zambia achieve good immunologic and virologic outcomes two years after initiating antiretroviral therapy. PLoS One (2011) 1.47
A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nat Med (2003) 1.39
Immunogenicity of standard-titer measles vaccine in HIV-1-infected and uninfected Zambian children: an observational study. J Infect Dis (2007) 1.38
Feasibility of satellite image-based sampling for a health survey among urban townships of Lusaka, Zambia. Trop Med Int Health (2008) 1.35
Differences in presentation, treatment initiation, and response among children infected with human immunodeficiency virus in urban and rural Zambia. Pediatr Infect Dis J (2010) 1.34
Reduced risk of malaria parasitemia following household screening and treatment: a cross-sectional and longitudinal cohort study. PLoS One (2012) 1.32
Suppression of human immunodeficiency virus replication during acute measles. J Infect Dis (2002) 1.31
Survival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapy. Clin Infect Dis (2008) 1.27
The changing burden of malaria and association with vector control interventions in Zambia using district-level surveillance data, 2006-2011. Malar J (2013) 1.25
Gamma interferon-dependent, noncytolytic clearance of sindbis virus infection from neurons in vitro. J Virol (2005) 1.25
Class II fusion protein of alphaviruses drives membrane fusion through the same pathway as class I proteins. J Cell Biol (2005) 1.25
Changes in the burden of malaria following scale up of malaria control interventions in Mutasa District, Zimbabwe. Malar J (2013) 1.24
Inhibition of HIV-1 replication in human lymphoid tissues ex vivo by measles virus. J Infect Dis (2005) 1.24
Age-dependent differences in IgG isotype and avidity induced by measles vaccine received during the first year of life. J Infect Dis (2007) 1.22
Weight and height z-scores improve after initiating ART among HIV-infected children in rural Zambia: a cohort study. BMC Infect Dis (2011) 1.21
Synergistic roles of antibody and interferon in noncytolytic clearance of Sindbis virus from different regions of the central nervous system. J Virol (2007) 1.21
Measles vaccines. Front Biosci (2008) 1.19
Measles: immune suppression and immune responses. Int J Biochem Cell Biol (2004) 1.18
Differential regulation of interleukin (IL)-4, IL-5, and IL-10 during measles in Zambian children. J Infect Dis (2002) 1.18
HIV-1 infection in Zambian children impairs the development and avidity maturation of measles virus-specific immunoglobulin G after vaccination and infection. J Infect Dis (2009) 1.17
Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles. Proc Natl Acad Sci U S A (2005) 1.16
Myelin basic protein-reactive autoantibodies in the serum and cerebrospinal fluid of multiple sclerosis patients are characterized by low-affinity interactions. J Neuroimmunol (2003) 1.16
Glutamate receptor antagonists protect from virus-induced neural degeneration. Ann Neurol (2004) 1.16
Protection from fatal viral encephalomyelitis: AMPA receptor antagonists have a direct effect on the inflammatory response to infection. Proc Natl Acad Sci U S A (2008) 1.15
Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. J Virol (2003) 1.15
Management and outcomes of intracranial tuberculomas developing during antituberculous therapy: case report and review. Clin Pediatr (Phila) (2005) 1.14
Prospective study of measles in hospitalized, human immunodeficiency virus (HIV)-infected and HIV-uninfected children in Zambia. Clin Infect Dis (2002) 1.14
Malaria research challenges in low prevalence settings. Malar J (2012) 1.14
Gene expression patterns in dendritic cells infected with measles virus compared with other pathogens. Proc Natl Acad Sci U S A (2006) 1.12
Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J (2010) 1.10
Contribution of T cells to mortality in neurovirulent Sindbis virus encephalomyelitis. J Neuroimmunol (2002) 1.10
Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling. J Virol (2009) 1.09
Risk factors for pre-treatment mortality among HIV-infected children in rural Zambia: a cohort study. PLoS One (2011) 1.09
Prolonged persistence of measles virus RNA is characteristic of primary infection dynamics. Proc Natl Acad Sci U S A (2012) 1.08
Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys. J Infect Dis (2004) 1.07
A single mutation in the E2 glycoprotein important for neurovirulence influences binding of sindbis virus to neuroblastoma cells. J Virol (2002) 1.07
The nsP3 macro domain is important for Sindbis virus replication in neurons and neurovirulence in mice. Virology (2009) 1.06
Efficiency of household reactive case detection for malaria in rural Southern Zambia: simulations based on cross-sectional surveys from two epidemiological settings. PLoS One (2013) 1.05
High burden of malaria following scale-up of control interventions in Nchelenge District, Luapula Province, Zambia. Malar J (2014) 1.04
Functional and phenotypic changes in circulating lymphocytes from hospitalized zambian children with measles. Clin Diagn Lab Immunol (2002) 1.04
Improved measles surveillance in Cameroon reveals two major dynamic patterns of incidence. Int J Infect Dis (2005) 1.04
Incidence of influenza virus infection in early infancy: a prospective study in South Asia. Pediatr Infect Dis J (2011) 1.03
Altered synthesis of interleukin-12 and type 1 and type 2 cytokinesin rhesus macaques during measles and atypical measles. J Infect Dis (2001) 1.00
In vitro suppression of human immunodeficiency virus type 1 replication by measles virus. J Virol (2005) 1.00
Immune-mediated clearance of virus from the central nervous system. Microbes Infect (2003) 1.00
A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles. J Virol (2010) 0.99
Dynamic regulation of functionally distinct virus-specific T cells. Proc Natl Acad Sci U S A (2010) 0.99
Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model. Int J Epidemiol (2008) 0.99
Secular trends in pediatric antiretroviral treatment programs in rural and urban Zambia: a retrospective cohort study. BMC Pediatr (2010) 0.99
BCL-2 and BAX protect adult mice from lethal Sindbis virus infection but do not protect spinal cord motor neurons or prevent paralysis. J Virol (2002) 0.99
Correlates of sexual activity and sexually transmitted infections among human immunodeficiency virus-infected youth in the LEGACY cohort, United States, 2006. Pediatr Infect Dis J (2011) 0.98
The association of Blastocystis hominis and Endolimax nana with diarrheal stools in Zambian school-age children. Parasitol Res (2005) 0.98
Extensive immune-mediated hippocampal damage in mice surviving infection with neuroadapted Sindbis virus. Virology (2003) 0.97
Rapid activation of poly(ADP-ribose) polymerase contributes to Sindbis virus and staurosporine-induced apoptotic cell death. Virology (2002) 0.97
Seasonal concentrations and determinants of indoor particulate matter in a low-income community in Dhaka, Bangladesh. Environ Res (2012) 0.97
Neonatal survival interventions in humanitarian emergencies: a survey of current practices and programs. Confl Health (2012) 0.97
Characterization of an in vitro model of alphavirus infection of immature and mature neurons. J Virol (2005) 0.97
Immunologic basis for revaccination of HIV-infected children receiving HAART. Future Virol (2011) 0.96
Heparin-binding and patterns of virulence for two recombinant strains of Sindbis virus. Virology (2005) 0.95
Research priorities for global measles and rubella control and eradication. Vaccine (2012) 0.95
HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin Infect Dis (2008) 0.95
Slow clearance of measles virus RNA after acute infection. J Clin Virol (2007) 0.95
Streptomyces bikiniensis bacteremia. Emerg Infect Dis (2003) 0.95
Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system. J Virol (2011) 0.95
Measles vaccination in HIV-infected children: systematic review and meta-analysis of safety and immunogenicity. J Infect Dis (2011) 0.94
Incidence and risk factors for Malaria, pneumonia and diarrhea in children under 5 in UNHCR refugee camps: A retrospective study. Confl Health (2011) 0.94
Role of N-linked glycosylation for sindbis virus infection and replication in vertebrate and invertebrate systems. J Virol (2009) 0.94
Estimating the force of measles virus infection from hospitalised cases in Lusaka, Zambia. Vaccine (2004) 0.94
Hemagglutinin protein is a primary target of the measles virus-specific HLA-A2-restricted CD8+ T cell response during measles and after vaccination. J Infect Dis (2007) 0.93
Changing individual-level risk factors for malaria with declining transmission in southern Zambia: a cross-sectional study. Malar J (2011) 0.93
Successful respiratory immunization with dry powder live-attenuated measles virus vaccine in rhesus macaques. Proc Natl Acad Sci U S A (2011) 0.91
Measles virus inhibits human immunodeficiency virus type 1 reverse transcription and replication by blocking cell-cycle progression of CD4+ T lymphocytes. J Gen Virol (2008) 0.91
Sprouty-2 regulates HIV-specific T cell polyfunctionality. J Clin Invest (2014) 0.90
Interaction of Sindbis virus non-structural protein 3 with poly(ADP-ribose) polymerase 1 in neuronal cells. J Gen Virol (2009) 0.90
Changes in measles serostatus among HIV-infected Zambian children initiating antiretroviral therapy before and after the 2010 measles outbreak and supplemental immunization activities. J Infect Dis (2013) 0.90
Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivity. Proc Natl Acad Sci U S A (2008) 0.89
The effect of measles-mumps-rubella (MMR) immunization on the immune responses of previously immunized primary school children. Vaccine (2003) 0.89